Xiu Feng Li
Director/Miembro de la Junta en CHANGCHUN BCHT BIOTECHNOLOGY CO. .
Fortuna: 244 730 $ al 30/04/2024
Perfil
Xiu Feng Li es director general adjunto de Changchun High & New Technology Industries (Group), Inc. y forma parte del consejo de administración de otras 8 empresas. El Sr. Li se licenció en la Universidad de Jilin.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 21/04/2023 | 15 675 ( 0.58% ) | 244 730 $ | 30/04/2024 |
Cargos activos de Xiu Feng Li
| Empresas | Cargo | Inicio |
|---|---|---|
| CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | Corporate Officer/Principal | 26/06/2018 |
| CHANGCHUN BCHT BIOTECHNOLOGY CO. | Director/Miembro de la Junta | 01/03/2004 |
| Changchun BCHT Pharmaceuticals Co. Ltd. | Director/Miembro de la Junta | 20/08/2010 |
| Changchun Chenguang Pharmaceutical Co. Ltd. | Director/Miembro de la Junta | 20/08/2010 |
| Jilin Maifeng Biological Pharmaceutical Co., Ltd. | Director/Miembro de la Junta | 20/08/2010 |
| Qinhuangdao Shanhaiguan Pharmaceutical Co. Ltd. | Director/Miembro de la Junta | 20/08/2010 |
Jilin Huakang Pharmaceutical Co. Ltd.
 Jilin Huakang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High & New Technology Industries (Group), Inc., Jilin Huakang Pharmaceutical Co. Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company is based in Dunhua, China. | Director/Miembro de la Junta | 12/03/2014 |
GeneScience Pharmaceuticals Co., Ltd.
 GeneScience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology GeneScience Pharmaceuticals Co., Ltd. engages in the production and sale of biopharmaceutical products. Its products include bioengineering products such as recombinant human growth hormones, active pharmaceutical ingredients such as tripplein acetate and alprostadil, freeze-dried powder injections, small volume injections, biological product intermediates, and medical devices. The company was founded by Lei Jin in 1996 and is headquartered in Changchun, China. | Director/Miembro de la Junta | 18/03/2014 |
Changchun Baiyi Pharmaceutical Co., Ltd.
 Changchun Baiyi Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Baiyi Pharmaceutical Co., Ltd. is a company that manufactures biological pharmaceutical products. Changchun Baiyi Pharmaceutical Co., Ltd. is based in Changchun, China. Changchun Baiyi Pharmaceutical Co. was acquired by Changchun BCHT Biotechnology Co. on June 14, 2013 for $1.67 million. | Director/Miembro de la Junta | 01/08/2013 |
| ░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ | - |
Formación de Xiu Feng Li.
| Jilin University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CHANGCHUN HIGH-TECH INDUSTRY (GROUP) CO., LTD. | Health Technology |
| CHANGCHUN BCHT BIOTECHNOLOGY CO. | Health Technology |
| Empresas privadas | 8 |
|---|---|
| Changchun BCHT Pharmaceuticals Co. Ltd. | |
| Changchun Chenguang Pharmaceutical Co. Ltd. | |
| Jilin Maifeng Biological Pharmaceutical Co., Ltd. | |
| Qinhuangdao Shanhaiguan Pharmaceutical Co. Ltd. | |
Jilin Huakang Pharmaceutical Co. Ltd.
Jilin Huakang Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High & New Technology Industries (Group), Inc., Jilin Huakang Pharmaceutical Co. Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company is based in Dunhua, China. | Health Technology |
GeneScience Pharmaceuticals Co., Ltd.
GeneScience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology GeneScience Pharmaceuticals Co., Ltd. engages in the production and sale of biopharmaceutical products. Its products include bioengineering products such as recombinant human growth hormones, active pharmaceutical ingredients such as tripplein acetate and alprostadil, freeze-dried powder injections, small volume injections, biological product intermediates, and medical devices. The company was founded by Lei Jin in 1996 and is headquartered in Changchun, China. | Health Technology |
Changchun Baiyi Pharmaceutical Co., Ltd.
Changchun Baiyi Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Baiyi Pharmaceutical Co., Ltd. is a company that manufactures biological pharmaceutical products. Changchun Baiyi Pharmaceutical Co., Ltd. is based in Changchun, China. Changchun Baiyi Pharmaceutical Co. was acquired by Changchun BCHT Biotechnology Co. on June 14, 2013 for $1.67 million. | Health Technology |
Changchun Genescience Pharmaceuticals Co., Ltd.
 Changchun Genescience Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Changchun High-Tech Industry (Group) Co., Ltd., Changchun Genescience Pharmaceuticals Co., Ltd. is a company that manufactures pharmaceutical products. Changchun Genescience Pharmaceuticals Co., Ltd. is based in Changchun, China. The Chinese company was founded in 1997. The CEO is Lei Jin. | Health Technology |
- Bolsa de valores
- Insiders
- Xiu Feng Li